We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

Meet the Scientists Bringing Back the Extinct Tasmanian Tiger

The biotech/genetic engineering company Colossal – co-founded in 2021 by renowned geneticist Professor George Church and serial entrepreneur Ben Lamm – announced it has begun a de-extinction project of the thylacine – an Australian marsupial commonly referred to as the “Tasmanian tiger”. Technology Networks interviewed the team to learn more.
Industry Insight

Broadening the Adoption of Pharmacogenomic Testing

Technology Networks recently had the pleasure of speaking to Dr. Philip Empey, to learn more about the Pharmacogenomics Center for Excellence and how it is working to prove the clinical utility of predictive PGx testing.
Industry Insight

A New Approach to T-Cell Therapy

In this interview with Bryan Kobel, CEO of TC Biopharm, we find out about gamma-delta T-cell therapy, including how it works, its applications and how TC Biopharm developed its pioneering gamma-delta treatment for acute myeloid leukemia.
Industry Insight

Novel Biosensor Aims To Help Fight Against Forever Chemicals

There is widespread concern about the characteristics of PFAS and its impacts on human health. Can a protein biosensor help in this fight?
Industry Insight

Machine Learning Helps Achieve Greater Depth in Proteome Analysis

To understand how machine learning methods and new software capabilities are helping proteomics researchers gain greater depth in their analyses, Technology Networks recently interviewed Tharan Srikumar, product manager in bioinformatics at Bruker Daltonics.
Industry Insight

A Paradigm Shift in Sepsis Diagnostics

In this interview, Rolland Carlson, PhD, CEO of Immunexpress, discusses sepsis and the company’s FDA cleared SeptiCyte® RAPID test, as well as a take on the company’s differentiated value and outlook.
Industry Insight

Exploring Flow Electroporation for Cell Engineering

Technology Networks spoke to Dr. Cenk Sumen, chief scientific officer of MaxCyte, about their pioneering cell engineering platform.
Industry Insight

Developing Therapeutics To Combat ALS

In this interview, we speak to Alon Ben-Noon, CEO and co-founder of Neurosense Therapeutics to hear about the impact their drug development strategy is having on the ALS field.
Industry Insight

Exploring the Ethical Challenges of Brain–Computer Interface Technology

This article explores the current state of brain-computer interface technology and some of the ethical considerations associated with its use.
Industry Insight

New Technology Aims To Accelerate Biopharma Development

Developing and manufacturing biotherapeutics at scale requires thorough analysis of the active substance’s characteristics to ensure it fulfils both efficacy and safety requirements. Analytical technologies, such as mass spectrometry, are key tools adopted in this process.
Advertisement